{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "G",
          "alt": "S",
          "position": "2019"
        },
        "variant_string_id": "LRRK2 G2019S"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper investigates the functional impact of LRRK2 variants on kinase activity and downstream signaling, which is relevant to the disease mechanism.",
          "judgment": "Yes",
          "reasoning": "The disease mechanism is defined through the analysis of kinase activity and phosphorylation, which are critical for understanding the pathogenicity of LRRK2 variants."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The assays used include kinase assays and western blot analysis with phosphospecific antibodies, which are standard methods for assessing kinase activity and phosphorylation.",
          "judgment": "Yes",
          "reasoning": "The general class of assays (kinase activity and phosphorylation) is appropriate for assessing the functional impact of LRRK2 variants.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The paper mentions the use of wild-type and mutant controls, and at least four independent data points were used for each mutant. Loading controls were performed as described.",
          "judgment": "Yes",
          "reasoning": "The assays include appropriate controls and replicates, indicating valid experimental design.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The data analysis was performed using Image Quant software, but specific statistical measures like p-values or OddsPath were not explicitly mentioned.",
          "judgment": "No",
          "reasoning": "While the data was analyzed using Image Quant software, the absence of explicit statistical measures or OddsPath values means we cannot proceed to Step 4c.",
          "next_step_or_outcome": "Proceed to Step 4b"
        },
        {
          "step_name": "Step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The paper mentions at least four independent data points for each mutant, but the total number of benign/pathogenic variant controls used across the study is not explicitly stated.",
          "judgment": "No",
          "reasoning": "The total number of benign/pathogenic variant controls is not explicitly stated, but the use of multiple replicates and controls suggests a moderate level of evidence.",
          "next_step_or_outcome": "The functional evidence strength is Max PS3_supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The evidence supports a pathogenic role for the LRRK2 G2019S variant, with moderate strength based on the functional assays and controls described."
    },
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "K",
          "alt": "M",
          "position": "1906"
        },
        "variant_string_id": "LRRK2 K1906M"
      },
      "functional_evidence_aim": "Benign",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper investigates the functional impact of LRRK2 variants on kinase activity and downstream signaling, which is relevant to the disease mechanism.",
          "judgment": "Yes",
          "reasoning": "The disease mechanism is defined through the analysis of kinase activity and phosphorylation, which are critical for understanding the benign nature of LRRK2 variants."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The assays used include kinase assays and western blot analysis with phosphospecific antibodies, which are standard methods for assessing kinase activity and phosphorylation.",
          "judgment": "Yes",
          "reasoning": "The general class of assays (kinase activity and phosphorylation) is appropriate for assessing the functional impact of LRRK2 variants.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The paper mentions the use of wild-type and mutant controls, and at least four independent data points were used for each mutant. Loading controls were performed as described.",
          "judgment": "Yes",
          "reasoning": "The assays include appropriate controls and replicates, indicating valid experimental design.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The data analysis was performed using Image Quant software, but specific statistical measures like p-values or OddsPath were not explicitly mentioned.",
          "judgment": "No",
          "reasoning": "While the data was analyzed using Image Quant software, the absence of explicit statistical measures or OddsPath values means we cannot proceed to Step 4c.",
          "next_step_or_outcome": "Proceed to Step 4b"
        },
        {
          "step_name": "Step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The paper mentions at least four independent data points for each mutant, but the total number of benign/pathogenic variant controls used across the study is not explicitly stated.",
          "judgment": "No",
          "reasoning": "The total number of benign/pathogenic variant controls is not explicitly stated, but the use of multiple replicates and controls suggests a moderate level of evidence.",
          "next_step_or_outcome": "The functional evidence strength is Max BS3_supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "Benign",
        "strength": "BS3_supporting"
      },
      "overall_conclusion": "The evidence supports a benign role for the LRRK2 K1906M variant, with moderate strength based on the functional assays and controls described."
    }
  ]
}